Dubin Thomas I H Insider Trades

Insider Trading History

Track insider trading activity for Dubin Thomas I H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intensity Therapeutics
Intensity Therapeutics INTS
Director
Holding Value $200k 50,000 shares
Last Trade
May 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.5k 50,000 shares
$0.57
$3.99
Intensity Therapeutics
Intensity Therapeutics INTS
Director
Holding Value $200k 50,000 shares
Last Trade
May 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 50,000 shares
$4.42
$3.99
Notable Labs
Notable Labs NTBL
Director
Holding Value $9.98k 40,247 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.9k 40,247 shares
$1.19
$0.25
Notable Labs
Notable Labs NTBL
Director
Holding Value $2.42k 9,753 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 9,753 shares
$1.28
$0.25
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $12M 65,705 shares
Last Trade
Aug 23, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$956k 9,200 shares
$103.87
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $13.7M 74,905 shares
Last Trade
Aug 23, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.51M 24,328 shares
$103.09
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $18.1M 99,233 shares
Last Trade
Jul 31, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.4k 680 shares
$104.94
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $45.4M 248,716 shares
Last Trade
Jul 27, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.77M 16,642 shares
$106.35
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $18.2M 99,913 shares
Last Trade
Jul 27, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.9k 668 shares
$106.14
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $48.4M 265,358 shares
Last Trade
Jul 27, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$663k 6,268 shares
$105.76
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $18.4M 100,581 shares
Last Trade
Jul 27, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.08M 28,200 shares
$109.28
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $33.4M 183,252 shares
Last Trade
Jul 27, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.01M 82,671 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $11.3M 61,876 shares
Last Trade
Jul 27, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.06M 28,124 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $11M 60,000 shares
Last Trade
Jul 27, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$436k 4,000 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $43.7M 239,502 shares
Last Trade
Jul 27, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.13M 56,250 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $2.33M 12,751 shares
Last Trade
Jul 27, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.01M 82,671 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $7.98M 43,750 shares
Last Trade
Jul 27, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.13M 56,250 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $36M 197,413 shares
Last Trade
Jul 27, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.52M 51,303 shares
$107.57
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $49.6M 271,626 shares
Last Trade
Jul 27, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$436k 4,000 shares
$108.97
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
SVP & Chief Legal Officer
Holding Value $48.8M 267,626 shares
Last Trade
Jul 27, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.06M 28,124 shares
$108.97
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up